Abstract
Multiple technologies which measure the same omics data set but are based on different aspects of the molecules exist. In practice, studies use different technologies and have therefore different biomarkers. An example is the glycan age index, which is constructed by three different ultra-performance liquid chromatography (UPLC) IgG glycans, and is a biomarker for biological age. A second technology is liquid chromatography-mass spectrometry (LCMS). To estimate the effect of a biomarker on an outcome variable, two issues need to be addressed. Firstly, a measurement error is needed to map one technology to the other one using a calibration study. Here, we consider two approaches, namely one based on the chemical properties of the two technologies and one based on the estimation of this relationship using O2PLS. Secondly, the use of an approximation of the biomarker in the main study needs to be taken into account by use of a regression calibration method. The performance of the two approaches is studied via simulations. The methods are used to estimate the relationship between glycan age and menopause. We have data from two cohorts, namely Korcula and Vis. In conclusion, (1) both measurement error models give similar results and suggest that there is an association between the glycan age index and the menopause status, (2) the chemical mapping approach outperforms O2PLS in the low measurement error variance, while on the larger measurement error variance, O2PLS works better, (3) statistical efficiency is lost due to increased noise level by adding irrelevant information. © 2021, Fabrizio Serra Editore Srl. All rights reserved.